Business Model: B2B Consulting
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Cybele Holdings Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Cybele Group is a full service consulting and financial services firm, which provides investment banking, brokerage and asset management services to both corporations and a wide array of clients, ranging from individuals and small businesses to the world&s;s largest corporations and governments.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2019 | UNIVO Pharmaceuticals | Post-IPO Equity | 3M |
| 5/2012 | Mazor Robotics | Venture Round | 3M |
| 8/2016 | Villar international | Post-IPO Equity | 30.3M |
| 12/2017 | Brainsway | Post-IPO Equity | 8.5M |
| 4/2015 | Hadasit | Venture Round | 14.6M |
| 7/2020 | Vonetize | Post-IPO Equity | 434.8k |
| 1/2020 | Israel Discount Bank | Post-IPO Equity | 29.1M |
| 12/2017 | Micromedic | Post-IPO Equity | 573.8k |
| 8/2019 | Cofix | Post-IPO Equity | 569.8k |
| 1/2011 | Yozma Group | Venture Round | 411.9k |
| 5/2020 | Micronet | Venture Round | 513k |
| 9/2019 | Micronet | Venture Round | 821.4k |
| 11/2007 | Netex | Venture Round | 2.3M |
| 11/2015 | Purple Biotech | Venture Round | 13.4M |
| 4/2019 | Sella Capital Real Estate | Post-IPO Equity | 73.1M |
| 2/2018 | Sella Capital Real Estate | Post-IPO Equity | 76.7M |
| 10/2015 | Copperline Partners | Venture Round | 86.4M |
| 2/2021 | Itamar Medical | Post-IPO Secondary | 70M |
| 9/2019 | CanFite BioPharma | Post-IPO Equity | 2.4M |
| 3/2003 | SolidCAM | Venture Round | 742.4k |
| 3/2015 | Purple Biotech | Venture Round | 2.1M |
| 1/2006 | Mango DSP | Series D | 2M |
| 2/2006 | Mango DSP | Venture Round | 2M |
| 8/2006 | WideMed | Venture Round | 1.4M |
| 6/2016 | Tower Semiconductor | Venture Round | 115.4M |
| 11/2019 | Medipower | Post-IPO Equity | 22.7M |
| 8/2018 | Hagag Group | Post-IPO Equity | 21.8M |
| 8/2009 | Sialo Technology | Venture Round | 2.2M |
| 1/2012 | D Pharm LTD. | Venture Round | 4.1M |
| 8/2021 | Smart Agro | Post-IPO Equity | 4.5M |
| 6/2017 | Amnis Therapeutics | Venture Round | 422.4k |
| 9/2016 | Israel Discount Bank | Post-IPO Equity | 153.7M |
| 3/2016 | Amnis Therapeutics | Venture Round | 771.4k |
| 1/2019 | Micromedic | Post-IPO Equity | 909.3k |
| 12/2019 | Fattal Hotels | Post-IPO Equity | 66.3M |
| 3/2014 | Alcobra Pharmaceuticals | Venture Round | 8.2M |
| 2/2021 | Protalix BioTherapeutics | Post-IPO Equity | 40M |
| 4/2012 | PROLOR Biotech | Venture Round | 2.3M |
| 10/2020 | Micronet | Venture Round | 12.3M |
| 6/2020 | Micronet | Venture Round | 1.1M |
| 2/2019 | Micronet | Venture Round | 1.4M |
| 9/2020 | NovoCure | Post-IPO Debt | 15.5M |
| 2/2014 | Insuline Medical | Post-IPO Equity | 711.6k |
| 8/2015 | optibase | Post-IPO Equity | 15.9M |
| 7/2017 | NovoCure | Post-IPO Equity | 13M |
| 4/2019 | Pharmocann | Post-IPO Equity | 69M |
| 10/2018 | Apply Mobile Technologies | Post-IPO Equity | 1.4M |
| 3/2017 | Ellomay Capital | Post-IPO Equity | 33.6M |
| 5/2017 | Accelmed | Venture Round | 6.4M |
| 2/2015 | Check-Cap | Post-IPO Equity | 23.2M |
| 9/2019 | Golden House | Post-IPO Equity | 21.2M |
| 7/2019 | Ayalon Insurance | Post-IPO Equity | 110M |
| 3/2014 | Alcobra Pharmaceuticals | Post-IPO Equity | 8.2M |
| 5/2020 | Steakholder Foods | Venture Round | 2.4M |
| 10/2017 | Duniec | Post-IPO Equity | 46.6M |
| 1/2014 | Oramed Pharmaceuticals | Post-IPO Equity | 3.5M |
| 5/2018 | BioLight Israeli Life Sciences Investments Ltd | Post-IPO Equity | 3.2M |
| 9/2017 | REIT1 | Post-IPO Equity | 31.3M |
| 10/2017 | Infimer | Venture Round | 2.4M |
| 12/2017 | Medical Compression Systems | Post-IPO Equity | 2.3M |
| 3/2019 | Cofix | Post-IPO Equity | 1.1M |
| 3/2010 | Anchiano Therapeutics | Venture Round | 3.4M |
| 8/2009 | Israel Healthcare Ventures | Venture Round | 4.4M |
| 7/2016 | PlastoSac | Venture Round | 27.8M |
| 7/2019 | UNIVO Pharmaceuticals | Post-IPO Equity | 1.5M |
| 12/2018 | Israel Discount Bank | Post-IPO Equity | 403.1M |
| 8/2019 | Eloxx | Post-IPO Equity | 2.3M |
| 2/2021 | Z.M.H Hammerman | Post-IPO Equity | 24.3M |
| 1/2019 | Naphtha Israel Petroleum | Venture Round | 112.9M |
| 11/2017 | PennantPark Investment Corp | Post-IPO Equity | 139.8M |
| 10/2019 | Duniec | Post-IPO Equity | 17.4M |
| 4/2007 | ZipZup | Venture Round | 240.5k |
| 6/2017 | Cofix | Post-IPO Equity | 1.4M |
| 1/2020 | Satcom Systems | Venture Round | 3M |
| 5/2010 | Netex | Venture Round | 1.5M |
| 7/2008 | Rosh Dio | Venture Round | 1.1M |
| 4/2013 | CanFite BioPharma | Post-IPO Equity | 1.4M |
| 7/2021 | Cannabotech | Venture Round | 8M |
| 6/2016 | Amnis Therapeutics | Venture Round | 519.2k |
| 8/2012 | Sponser | Venture Round | 3.8M |
| 5/2010 | SolidCAM | Venture Round | 10.7M |
| 11/2017 | Nisko | Venture Round | 28.5M |
| 10/2009 | Netex | Venture Round | 1.9M |
| 6/2022 | Silverbyte | Venture Round | 35.9M |
| 1/2017 | Ratio Petroleum Energy | Venture Round | 30.5M |
| 12/2015 | Itamar Medical | Venture Round | 4.8M |
| 1/2008 | Mango DSP | Venture Round | 12.5M |
| 11/2015 | Klein Group | Venture Round | 53M |
| 2/2020 | Opal Balance | Post-IPO Equity | 8.7M |
| 5/2019 | Ashdar | Venture Round | 50.2M |
| 6/2016 | Endymed | Venture Round | 1.1M |
| 12/2009 | BioLight Israeli Life Sciences Investments Ltd | Venture Round | 3.2M |
| 11/2016 | Amnis Therapeutics | Venture Round | 524.1k |
| 12/2019 | Bezeq International | Venture Round | 98M |
| 10/2015 | Bezeq International | Venture Round | 200.4M |
| 10/2007 | Hevre | Venture Round | 1.1M |
| 7/2010 | Alice Ventures | Venture Round | 7.2M |
| 6/2014 | Azrieli.com | Venture Round | 2M |
| 4/2019 | Ashdar | Venture Round | 11.7M |
| 3/2018 | Itamar Medical | Venture Round | 6.4M |
| 12/2020 | Millenium Food-Tech | Venture Round | 16.1M |
| 6/2016 | Accelmed | Venture Round | 5.7M |
| 1/2010 | Maayan Ventures | Venture Round | 11.4M |
| 5/2010 | Medigus | Venture Round | 3.8M |
| 12/2005 | Maximedia | Venture Round | 6.1M |
| 1/2010 | Itamar Medical | Venture Round | 6.5M |
| 1/2014 | Itamar Medical | Venture Round | 9.7M |
| 1/2013 | Itamar Medical | Venture Round | 20.1M |
| 8/2007 | Mazor Robotics | Venture Round | 12M |
| 2/2012 | Dafna Capital Management | Venture Round | 2M |
| 11/2015 | Jobookit Technologies | Venture Round | 905.3k |
| 5/2014 | Itamar Medical | Venture Round | 7.7M |
| 6/2013 | Globe Exploration | Venture Round | 11.4M |
| 10/2018 | Globe Exploration | Venture Round | 1.1M |
| 7/2020 | Dafna Capital Management | Venture Round | 10.7M |
| 2/2013 | Dafna Capital Management | Venture Round | 4.1M |
| 1/2014 | Dafna Capital Management | Venture Round | 1.4M |
| 2/2021 | Homebiogas | Venture Round | 30.3M |
| 6/2022 | Silverbyte | Venture Round | 0 |
| 8/2021 | Smart Agro | Post-IPO Equity | 0 |
| 7/2021 | Cannabotech | Venture Round | 0 |
| 2/2021 | Protalix BioTherapeutics | Post-IPO Equity | 0 |
| 2/2021 | Itamar Medical | Post-IPO Secondary | 0 |
| 2/2021 | Z.M.H Hammerman | Post-IPO Equity | 0 |
| 2/2021 | Homebiogas | Venture Round | 0 |
| 12/2020 | Millenium Food-Tech | Venture Round | 0 |
| 10/2020 | Micronet | Venture Round | 0 |
| 9/2020 | NovoCure | Post-IPO Debt | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
